Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jorddy N. Cruz, José F. S. Costa, André S. Khayat, Kamil Kuca, Carlos A. L. Barros & A. M. J. C. Neto. (2019) Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13. Journal of Biomolecular Structure and Dynamics 37:6, pages 1616-1627.
Read now
Read now
Nafsika H Georgopapadakou. (2014) Prospects for new antibacterials: can we do better?. Expert Opinion on Investigational Drugs 23:2, pages 145-148.
Read now
Read now
Yitzhak Rosen & Noel M Elman. (2009) Carbon nanotubes in drug delivery: focus on infectious diseases. Expert Opinion on Drug Delivery 6:5, pages 517-530.
Read now
Read now
Articles from other publishers (26)
Palka Mittal, Puneeta Ajmera, Vineet Jain & Gaurav Aggarwal. (2021) Modeling and analysis of barriers in controlling TB: developing countries' perspective. International Journal of Health Governance 26:4, pages 362-383.
Crossref
Crossref
Umar Ndagi, Hezekiel M. Kumalo & Ndumiso N. Mhlongo. (2021)
A consequence of drug targeting of aminoacyl‐tRNA synthetases in
Mycobacterium
tuberculosis
. Chemical Biology & Drug Design 98:3, pages 421-434.
Crossref
Crossref
Ana Guardia, Gulcin Gulten, Raquel Fernandez, Jesus Gómez, Feng Wang, Maire Convery, Delia Blanco, María Martínez, Esther Pérez-Herrán, Marta Alonso, Fátima Ortega, Joaquín Rullás, David Calvo, Lydia Mata, Robert Young, James C. Sacchettini, Alfonso Mendoza-Losana, Modesto Remuiñán, Lluís Ballell Pages & Julia Castro-Pichel. (2016)
N
-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-
trans
Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity
. ChemMedChem 11:7, pages 687-701.
Crossref
Crossref
Y. Hu, B. Mathema, Q. Zhao, L. Chen, W. Lu, W. Wang, B. Kreiswirth & B. Xu. (2015) Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China. Clinical Microbiology and Infection 21:12, pages 1093.e9-1093.e18.
Crossref
Crossref
Sudip Pal, Gajendra Singh, Shyam Singh, Jitendra Kumar Tripathi, Jimut Kanti Ghosh, Sudhir Sinha, Ravi Sankar Ampapathi & Tushar Kanti Chakraborty. (2015) Tetrahydrofuran amino acid-containing gramicidin S analogues with improved biological profiles. Organic & Biomolecular Chemistry 13:24, pages 6789-6802.
Crossref
Crossref
José AriasYitzhak Rosen & Pablo Gurman. 2014. Nanotechnology and Drug Delivery, Volume One. Nanotechnology and Drug Delivery, Volume One
233
248
.
Thomas Manning, Rachel Mikula, Hilary Lee, Aaron Calvin, Jarrett Darrah, Greg Wylie, Dennis Phillips & Benjamin J. Bythell. (2014) The copper (II) ion as a carrier for the antibiotic capreomycin against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters 24:3, pages 976-982.
Crossref
Crossref
Eduard R. Shmalenyuk, Larisa N. Chernousova, Inna L. Karpenko, Sergey N. Kochetkov, Tatiana G. Smirnova, Sofia N. Andreevskaya, Alexander O. Chizhov, Olga V. Efremenkova & Ludmila A. Alexandrova. (2013) Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides. Bioorganic & Medicinal Chemistry 21:17, pages 4874-4884.
Crossref
Crossref
Benjamin C. Jennings, Kristin J. Labby, Keith D. Green & Sylvie Garneau-Tsodikova. (2013) Redesign of Substrate Specificity and Identification of the Aminoglycoside Binding Residues of Eis from Mycobacterium tuberculosis. Biochemistry 52:30, pages 5125-5132.
Crossref
Crossref
Hyejin Kim, Minji Seo, Young Kil Park, Jae-Il Yoo, Yeong Seon Lee, Gyung Tae Chung & Sungweon Ryoo. (2013)
Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of
Mycobacterium tuberculosis
. Tuberculosis Research and Treatment 2013, pages 1-6.
Crossref
Crossref
Ajay Poudel, Bhagwan Maharjan, Chie Nakajima, Yukari Fukushima, Basu D. Pandey, Antje Beneke & Yasuhiko Suzuki. (2013) Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal. Tuberculosis 93:1, pages 84-88.
Crossref
Crossref
Rashed Noor, Safia Akhter, Farjana Rahman, Saurab Kishore Munshi, S.M. Mostofa Kamal & Farahnaaz Feroz. (2013) Frequency of extensively drug-resistant tuberculosis (XDR-TB) among re-treatment cases in NIDCH, Dhaka, Bangladesh. Journal of Infection and Chemotherapy 19:2, pages 243-248.
Crossref
Crossref
Travis C. Porco, Daozhou Gao, James C. Scott, Eunha Shim, Wayne T. Enanoria, Alison P. Galvani & Thomas M. Lietman. (2012) When Does Overuse of Antibiotics Become a Tragedy of the Commons?. PLoS ONE 7:12, pages e46505.
Crossref
Crossref
Juan Zhang, Ligu Mi, Yuanzhi Wang, Peizhi Liu, Haiyan Liang, Yi Huang, Bing Lv & Li Yuan. (2012) Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China. BMC Research Notes 5:1.
Crossref
Crossref
Wenjing Chen, Keith D. Green, Oleg V. Tsodikov & Sylvie Garneau-Tsodikova. (2012)
Aminoglycoside Multiacetylating Activity of the Enhanced Intracellular Survival Protein from
Mycobacterium smegmatis
and Its Inhibition
. Biochemistry 51:24, pages 4959-4967.
Crossref
Crossref
M. M. Abuali, R. Katariwala & V. J. LaBombardi. (2011) A comparison of the Sensititre® MYCOTB panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases 31:5, pages 835-839.
Crossref
Crossref
Salman Siddiqi, Altaf Ahmed, Sunil Asif, Digamber Behera, Mona Javaid, Jasmine Jani, Arora Jyoti, Radhika Mahatre, Dewanand Mahto, Elvira Richter, Camilla Rodrigues, Potharaju Visalakshi & Sabine Rüsch-Gerdes. (2012) Direct Drug Susceptibility Testing of Mycobacterium tuberculosis for Rapid Detection of Multidrug Resistance Using the Bactec MGIT 960 System: a Multicenter Study. Journal of Clinical Microbiology 50:2, pages 435-440.
Crossref
Crossref
Yitzhak Rosen, Brandon Mattix, Apparao Rao & Frank Alexis. 2011. Nanomedicine in Health and Disease. Nanomedicine in Health and Disease.
Padmakar Pandit & Smita Tiwari. (2011) Recent advances in the chemotherapy of tuberculosis. Indian Journal of Rheumatology 6:1, pages 95-98.
Crossref
Crossref
H. Zhang, P. Peng, S. Miao, Y. Zhao, F. Mao, L. Wang, Y. Bai, Z. Xu, S. Wei & C. Shi. (2010) Recombinant Mycobacterium smegmatis Expressing an ESAT6-CFP10 Fusion Protein Induces Anti-Mycobacterial Immune Responses and Protects Against Mycobacterium tuberculosis Challenge in Mice. Scandinavian Journal of Immunology 72:4, pages 349-357.
Crossref
Crossref
Heather M. Vinson, Ablesh Gautam, Susan Olet, Penelope S. Gibbs & Robert Barigye. (2010) Molecular analysis of porin gene transcription in heterogenotypic multidrug-resistant Escherichia coli isolates from scouring calves. Journal of Antimicrobial Chemotherapy 65:9, pages 1926-1935.
Crossref
Crossref
Benjamin B. Kaufmann & Deborah T. Hung. (2010) The Fast Track to Multidrug Resistance. Molecular Cell 37:3, pages 297-298.
Crossref
Crossref
S.-Y. Grace Lin, Edward Desmond, Donald Bonato, Wendy Gross & Salman Siddiqi. (2009)
Multicenter Evaluation of Bactec MGIT 960 System for Second-Line Drug Susceptibility Testing of
Mycobacterium tuberculosis
Complex
. Journal of Clinical Microbiology 47:11, pages 3630-3634.
Crossref
Crossref
Dieter Haebich & Franz von Nussbaum. (2009) Lost in Transcription-Inhibition of RNA Polymerase. Angewandte Chemie International Edition 48:19, pages 3397-3400.
Crossref
Crossref
Dieter Haebich & Franz von Nussbaum. (2009) Sand im Getriebe - Inhibition der RNA-Polymerase. Angewandte Chemie 121:19, pages 3447-3451.
Crossref
Crossref
Kamalini Lokuge, Kebei Salee & Anastasios Konstantinos. (2012) Tuberculosis Control in the Torres Strait Region: What's Needed and Why? Report Following a Public Forum. SSRN Electronic Journal.
Crossref
Crossref